Fluoroquinolone-Associated Myasthenia Gravis Exacerbation: Evaluation of Postmarketing Reports from the US FDA Adverse Event Reporting System and a Literature Review

Author: Jones S. Christopher   Sorbello Alfred   Boucher Robert M.  

Publisher: Adis International

ISSN: 0114-5916

Source: Drug Safety, Vol.34, Iss.10, 2011-10, pp. : 839-847

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content